C. R. Bard, Inc. v. Boston Scientific Corporation
Economic Advice in Litigation
The Situation
The defendant in a suit brought by C.R. Bard was found to have infringed on Bard's patent on esophageal balloon catheters.
NERA's Role
NERA calculated damages caused by the infringer's sales totaled more than $10 million.
The Result
The Delaware jury awarded C. R. Bard $10,820,000 in damages, an amount equaling 95 percent of NERA's damages calculation and far greater than the figure urged by the defendant and its expert.
